no code implementations • 28 Jun 2018 • Ansh Kapil, Armin Meier, Aleksandra Zuraw, Keith Steele, Marlon Rebelatto, Günter Schmidt, Nicolas Brieu
The level of PD-L1 expression in immunohistochemistry (IHC) assays is a key biomarker for the identification of Non-Small-Cell-Lung-Cancer (NSCLC) patients that may respond to anti PD-1/PD-L1 treatments.
